Michael T. Sweeney
Chief Tech/Sci/R&D Officer at RESVERLOGIX CORP.
Net worth: 6 523 $ as of 2024-03-30
Profile
Michael T.
Sweeney is a professional with a career history that includes several positions in the pharmaceutical industry.
He is currently the Senior Vice President-Clinical Development at Resverlogix Corp.
Prior to this, he held positions at Assertio Therapeutics, Inc. as the Chief Medical Officer, VP-Research & Development, at CV Therapeutics, Inc. as the Vice President-Medical Affairs, and at Pfizer Inc. as the Senior Director-Urology Global Medial Group Leader.
He also worked as a Senior Clinical Pharmacologist at Zeneca Group Plc.
Sweeney received his undergraduate degree from The University of Manchester, his doctorate from The University of Liverpool, and his graduate degree from the University of London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RESVERLOGIX CORP.
0.06% | 2023-03-02 | 155,312 ( 0.06% ) | 6 523 $ | 2024-03-30 |
Michael T. Sweeney active positions
| Companies | Position | Start |
|---|---|---|
| RESVERLOGIX CORP. | Chief Tech/Sci/R&D Officer | 2014-11-02 |
Former positions of Michael T. Sweeney
| Companies | Position | End |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Tech/Sci/R&D Officer | 2013-12-31 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Chief Tech/Sci/R&D Officer | 2007-08-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2002-12-31 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Corporate Officer/Principal | - |
Training of Michael T. Sweeney
| The University of Manchester | Undergraduate Degree |
| The University of Liverpool | Doctorate Degree |
| University of London | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| RESVERLOGIX CORP. | Health Technology |
| Private companies | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Health Technology |
- Stock Market
- Insiders
- Michael T. Sweeney
